While only exceptional cases of CALR-mutant polycythemia vera (PV) have been described in cases that were negative for JAK2V617F [5], 15–24 % and 25–35 % of patients with ET and PMF, respectively, carry a CALR mutation [3]. The gene discussed is CALR; the disease is essential thrombocythemia.